상품명칭: | (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9, 11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5, 12-dione |
CAS 레지스트리 번호: | 23214-92-8 |
EINECS: | 245-495-6 |
동의어: |
Adriamycin; Adriablastin; Doxil; Doxorubicinum; Adriblastin; Doxorubicine; Adriblastina; Myocet;(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9, 11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5, 12-dione; Rubex; |
분자 구조: | |
분자식: | C27H29NO11 |
분자량: | 543.51926 |
밀도: | 1.61 g/cm3 |
비등점: | RELATIVE DENSITY |
녹는점: | 205℃ |
인화점: | 443.8 °C |
굴절률: | 1.709 |
안전 문장: | Confirmed carcinogen with experimental carcinogenic, neoplastigenic, and tumorigenic data. Poison by intraperitoneal, subcutaneous, parenteral, and intravenous routes. Human systemic effects by intravenous route: cardiac myopathy including infarction, nausea or vomiting, and effects on the hair. An experimental teratogen. Other experimental reproductive effects. Human mutation data reported. When heated to decomposition it emits very toxic fumes of NOx and HCl. |
위험 기호: | UN NO. |